Alnuctamab | m-entrepreneurship.com

Product Name :
Alnuctamab

Search keywords :
Alnuctamab

drugId :
null

Target Vo:
T cell surface glycoprotein CD3

Target Vo Short Name :
CD3

Moa_Name:
T cell surface glycoprotein CD3 modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Engmab Ag

Active Company_Name :
Bristol-Myers Squibb (China) Investment Co Ltd

Active Indication_Name:
Multiple Myeloma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Transferrin Receptor 1 Antibody
SUMO1 Antibody (YA046)
Plant Actin Antibody (YA881): Plant Actin Antibody (YA881) is an unconjugated, approximately 42 kDa, mouse-derived, anti-Plant Actin (YA881) monoclonal antibody. Plant Actin Antibody (YA881) can be used for: WB expriments in Oryza sativa L, Brassica napus background without labeling.

Author: Betaine hydrochloride

Related Posts